161
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Effect Of E-OA-07 On Improving Joint Health And Mobility In Individuals With Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study

ORCID Icon, & ORCID Icon
Pages 3365-3379 | Published online: 18 Dec 2019

References

  • Mobasheri A. The future of osteoarthritis therapeutics: targeted pharmacological therapy. Curr Rheumatol Rep. 2013;15(10):364. doi:10.1007/s11926-013-0364-924061701
  • Zhang W, Ouyang H, Dass CR, Xu J. Current research on pharmacologic and regenerative therapies for osteoarthritis. Bone Res. 2016;4:15040. doi:10.1038/boneres.2015.4026962464
  • U. S. Food and Drug Administration. Center for Drug Evaluation and Research. FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes: FDA Drug Safety Communication; 2015 https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-strengthens-warning-non-aspirin-nonsteroidal-anti-inflammatory.
  • Yocum D, Fleischmann R, Dalgin P, Caldwell J, Hall D, Roszko P. Safety and efficacy of meloxicam in the treatment of osteoarthritis: a 12-Week, double-blind, multiple-dose, placebo-controlled trial. Arch Intern Med. 2000;160(19):2947–2954. doi:10.1001/archinte.160.19.294711041902
  • Hawker GA, White D, Skou ST. Non-pharmacological management of osteoarthritis. Osteoarthritis Cartilage. 2017;25(1):S4. doi:10.1016/j.joca.2017.02.013
  • Villafañe JH. Exercise and osteoarthritis: an update. J Exerc Rehabil. 2018;14(4):538–539. doi:10.12965/jer.1836352.17630276170
  • Szychlinska MA, Castrogiovanni P, Trovato FM, et al. Physical activity and Mediterranean diet based on olive tree phenolic compounds from two different geographical areas have protective effects on early osteoarthritis, muscle atrophy and hepatic steatosis. Eur J Nutr. 2019;58(2):565–581. doi:10.1007/s00394-018-1632-229450729
  • Castrogiovanni P, Di Rosa M, Ravalli S, et al. Moderate physical activity as a prevention method for knee osteoarthritis and the role of synoviocytes as biological key. Int J Mol Sci. 2019;20(3):511. doi:10.3390/ijms20030511
  • Ambrose KR, Golightly YM. Physical exercise as non-pharmacological treatment of chronic pain: why and when. Best Pract Res Clin Rheumatol. 2015;29(1):120–130. doi:10.1016/j.berh.2015.04.02226267006
  • Leach MJ, Kumar S. The clinical effectiveness of Ginger (Zingiber officinale) in adults with osteoarthritis. Int J Evid Based Healthc. 2008;6(3):311–320. doi:10.1111/j.1744-1609.2008.00106.x21631828
  • Bartels EM, Folmer VN, Bliddal H, et al. Efficacy and safety of ginger in osteoarthritis patients: a meta-analysis of randomized placebo-controlled trials. Osteoarthritis Cartilage. 2015;23(1):13–21. doi:10.1016/j.joca.2014.09.02425300574
  • Haroyan A, Mukuchyan V, Mkrtchyan N, et al. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study. BMC Complement Altern Med. 2018;18(1):7. doi:10.1186/s12906-017-2062-z29316908
  • Daily JW, Yang M, Park S. Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: a systematic review and meta-analysis of randomized clinical trials. J Med Food. 2016;19(8):717–729. doi:10.1089/jmf.2016.370527533649
  • Kulkarni MP, Shakeel A, Shinde BS, Rosenbloom RA. Efficacy and safety of E-OA-07 in moderate to severe symptoms of osteoarthritis: a double-blind randomized placebo-controlled study. Am J Ther. 2011;18(2):170–177. doi:10.1097/MJT.0b013e318209df4921317618
  • Girandola RN, Srivastava S, Loullis CC. A clinical trial comparing Lanconone® with ibuprofen for rapid relief in acute joint pain. Trials. 2016;17:189. doi:10.1186/s13063-016-1268-627052991
  • Kohn MD, Sassoon AA, Fernando ND. Classifications in brief: Kellgren-Lawrence classification of osteoarthritis. Clin Orthop Relat Res. 2016;474(8):1886–1893. doi:10.1007/s11999-016-4732-426872913
  • Chopra A, Lavin P, Patwardhan B, Chitre D. Randomized double blind trial of an ayurvedic plant derived formulation for treatment of rheumatoid arthritis. J Rheumatol. 2000;27(6):1365–1372. PMID: 10852255.10852255
  • EuroQol Group. EuroQol–a new facility for the measurement of health related quality of life. Hlth Pol. 1990;16:199–208. doi:10.1016/0168-8510(90)90421-9
  • Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–1736. doi:10.1007/s11136-011-9903-x21479777
  • Wyrwich KW, Kawata AK, Thompson C, Holmstrom S, Stoker M, Wiklund I. Validation of the self-assessment of treatment questionnaire among patients with postherpetic neuralgia. Pain Res Treat. 2012;2012:621619. doi:10.1155/2012/62161922937238
  • Stürmer T, Brenner H, Koenig W, Günther KP. Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein. Ann Rheum Dis. 2004;63(2):200–205. doi:10.1136/ard.2003.00767414722211
  • Bonnet CS, Walsh DA. Osteoarthritis, angiogenesis and inflammation. Rheumatology. 2005;44(1):7–16. doi:10.1093/rheumatology/keh34415292527
  • Castrogiovanni P, Trovato FM, Loreto C, Nsir H, Szychlinska MA, Musumeci G. Nutraceutical supplements in the management and prevention of osteoarthritis. Int J Mol Sci. 2016;17(12):2042. doi:10.3390/ijms17122042
  • Ha CW, Park YB, Min BW, et al. Prospective, randomized, double-blinded, double-dummy and multicenter phase IV clinical study comparing the efficacy and safety of PG201 (Layla) and SKI306X in patients with osteoarthritis. J Ethnopharmacol. 2016;181:1–7. doi:10.1016/j.jep.2016.01.02926821189
  • Park YG, Ha CW, Han CD, et al. A prospective, randomized, double-blind, multicenter comparative study on the safety and efficacy of Celecoxib and GCSB-5, dried extracts of six herbs, for the treatment of osteoarthritis of knee joint. J Ethnopharmacol. 2013;149(3):816–824. doi:10.1016/j.jep.2013.08.00823954277
  • Wang A, Leong DJ, Cardoso L, Sun HB. Nutraceuticals and osteoarthritis pain. Pharmacol Ther. 2018;187:167–179. doi:10.1016/j.pharmthera.2018.02.01529481810
  • Majeed M, Majeed S, Narayanan NK, Nagabhushanam K. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee. Phytother Res. 2019;33(5):1457–1468. doi:10.1002/ptr.633830838706
  • Lugo JP, Saiyed ZM, Lane NE. Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study. Nutr J. 2016;15:14. doi:10.1186/s12937-016-0130-826822714
  • Dueñas M, Ojeda B, Salazar A, Mico JA, Failde I. A review of chronic pain impact on patients, their social environment and the health care system. J Pain Res. 2016;9:457–467. doi:10.2147/JPR.S10589227418853
  • Smith JW, Martins TB, Gopez E, Johnson T, Hill HR, Rosenberg TD. Significance of C-reactive protein in osteoarthritis and total knee arthroplasty outcomes. Ther Adv Musculoskelet Dis. 2012;4(5):315–325. doi:10.1177/1759720X1245595923024709
  • Barbe MF, Barr AE. Inflammation and the pathophysiology of work-related musculoskeletal disorders. Brain Behav Immun. 2006;20(5):423–429. doi:10.1016/j.bbi.2006.03.00116647245
  • Zhang J. Meta-analysis of serum C-reactive protein and cartilage oligomeric matrix protein levels as biomarkers for clinical knee osteoarthritis. BMC Musculoskelet Disord. 2018;19(1):22. doi:10.1186/s12891-018-1932-y29351749
  • Czarnywojtek A, Owecki M, Zgorzalewicz-Stachowiak M, et al. The role of serum C-reactive protein measured by high-sensitive method in thyroid disease. Arch Immunol Ther Exp (Warsz). 2014;62(6):501–509. doi:10.1007/s00005-014-0282-124794233
  • Kolb-Bachofen V. A review on the biological properties of C-reactive protein. Immunobiology. 1991;183(1–2):133–145. doi:10.1016/S0171-2985(11)80193-21937562
  • Che W, Zhang B, Liu W, Wei Y, Xu Y, Hu D. Association between high-sensitivity C-reactive protein and N-Terminal Pro-B-Type natriuretic peptide in patients with hepatitis C virus infection. Mediators Inflamm. 2012;2012:730923. doi:10.1155/2012/73092322645408
  • Jin J, Sklar GE, Min Sen Oh V, Chuen, Li S. Factors affecting therapeutic compliance: a review from the patient’s perspective. Ther Clin Risk Manag. 2008;4(1):269–286. doi:10.2147/tcrm.s145818728716